Diabetes Peripheral Neuropathy and Small-fibre Nerve Damage: A Comparative Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-06-30

Study Completion Date

2013-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate whether patients with diabetes-related peripheral neuropathic pain also have non-recognized damage to the intestine caused by autonomic neuropathy. The model will shed light on aspects of peripheral nerve injuries on both somatic and as well as visceral sensory nerves. Classical autonomic parameters from electrocardiography (ECG) and Holter (24-h ECG and blood pressure) are compared with peripheral nerve injuries. The damage of autonomic nerves often recognized late in the course when patients develop gastroparesis, however an earlier recognition of this nerve damage may help clarifying the fundamental pathomechanisms and thereby optimize treatment for this patient group in the future.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Polyneuropathy in Diabetes Mellitus Type 2

NCT02947828

Diabetes Mellitus Type 2 Without Complication Polyneuropathies, Diabetic Diabetes Complications +2 more

COMPLETED

Comparison of Histamine and Local Heating for Evoking the Axon-reflex Flare Response in Diabetes

NCT05921097

Diabetes Diabetes Mellitus, Type 1 Diabetic Neuropathy Peripheral +1 more

COMPLETED

Differential Characteristics of Neuropathy in Type 2 Diabetics With and Without Lower Extremity Wounds

NCT02347709

Diabetic Foot Ulcer Diabetic Neuropathy Type 2 Diabetes

WITHDRAWN

Diffusion Tensor Imaging of Sural Nerves in Diabetic Peripheral Neuropathy

NCT00835757

Diabetic Peripheral Neuropathy

COMPLETED

Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy

NCT04699734

Painful Diabetic Neuropathy Neuropathic Pain Neuropathy;Peripheral

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus Peripheral Neuropathy Small Fibre Neuropathy Autonomic Neuropathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with diabetic peripheral neuropathy

No interventions assigned to this group

Healthy matched controls

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male or female patients between 18 and 75 years with diagnosed diabetes mellitus, according to WHO criteria (World Health Organization).
2. Proven peripheral neuropathy.
3. Oral and written consent, with documentation that all relevant information about the program is given to the patient.
4. The patient must be willing and able to, to meet the planned visit and meet the planned curriculum, including the participation in the experimental investigations.

Exclusion Criteria

1. Pregnancy or breastfeeding
2. Medical or surgical disease for the study doctor's assessment makes the patient unsuitable for participation in the study
3. Previous or ongoing major depression
4. Patients who can or will not comply with the recommended instructions given by the study doctor
5. Use of analgesic opioid medication less than 24 hours before screening
6. Competitive conditions that can cause peripheral neuropathy (eg, herpes zooster)
7. Clinically significant disease less than 2 weeks from the planned entry in the study
8. People involved in the planning or execution of the study

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes